Maurie Markman, MD
Some subjects in clinical medicine appear to be out-of bounds for open discussion. Consider the recent story in an otherwise prudent newspaper (The Jerusalem Post
) that a pharmaceutical company that had only tested a novel drug in mice would have “a cure for cancer within a year.”1
Of course, once it was printed in this newspaper, other media outlets reported the same nonsense. So, the question to be asked is: To what degree should reputable journalists and mainstream news organizations ensure at least a modest degree of authenticity in their reporting?
... to read the full story